Kotak Mahindra Bank - Systematix Retains 'Buy' Rating On The Stock After Its Q2 Results; Here's Why

Asset quality deterioration in unsecured credit was key disappointment, adds the brokerage.

Kotak Mahindra Bank branch. (Photo source: Vijay Sartape/ NDTV Profit)

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Research Report

Kotak Mahindra Bank Ltd. reported Q2 FY25 profit after tax of Rs 33.4 billion (-46.5% QoQ, +5% YoY). Notwithstanding the net interest margin decline, operating profit growth (ex-subsidiary dividend in Q1) was a decent number and was led by higher other income and moderate opex growth.

However, asset quality deterioration in older vintages in MFI and credit cards, with 48 bps QoQ worsening in slippage ratio, was the main disappointment resulting in earnings coming below estimate.

Click on the attachment to read the full report:

Systematix Kotak Mahindra Bank Q2 FY25 Results Review.pdf
Read Document

Also Read: Dolat Capital Maintains 'Buy' Rating On Kotak Mahindra Bank After Q2 Results

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story
Subscribe to unlock & enjoy all
Members-only benefits
Still Not convinced ?  Know More
Watch LIVE TV , Get Stock Market Updates, Top Business , IPO and Latest News on NDTV Profit.
GET REGULAR UPDATES